- Q4 2023 HALEON PLC Pre-Recorded Earnings Presentation TranscriptFeb 29, 2024
- Q4 2023 HALEON PLC Earnings Call TranscriptFeb 29, 2024€3.93 (+5.63%)Earnings
- HALEON PLC first Haleon Oral Health TranscriptDec 07, 2023
- Q3 2023 HALEON PLC Trading Statement Call TranscriptNov 02, 2023
- Half Year 2023 HALEON PLC Earnings Call TranscriptAug 02, 2023€3.76 (-3.23%)Earnings
- Half Year 2023 HALEON PLC Earnings Presentation (Pre-recorded) TranscriptAug 02, 2023
- HALEON PLC at Exane CEO Conference TranscriptJun 08, 2023
- Q1 2023 HALEON PLC Trading Statement Call TranscriptMay 03, 2023
- Haleon PLC Fireside Chat with Societe Generale SA TranscriptMar 23, 2023
- Full Year 2022 HALEON PLC Earnings Call (Q&A) TranscriptMar 02, 2023€3.56 (-2.73%)Earnings
- Full Year 2022 HALEON PLC Earnings Presentation (Pre-Recorded) TranscriptMar 02, 2023
- HALEON PLC at Redburn CEO Conference TranscriptNov 30, 2022
- Q3 2022 HALEON PLC Trading Statement Call TranscriptNov 10, 2022
- HALEON PLC at Sanford C Bernstein Pan European Strategic Decisions Conference TranscriptSep 28, 2022
- Half Year 2022 HALEON PLC Earnings Presentation (Pre-recorded) TranscriptSep 20, 2022
- Half Year 2022 HALEON PLC Earnings Call (Q&A) TranscriptSep 20, 2022€2.98 (-0.17%)Earnings
- HALEON PLC at Deutsche Bank dbAccess Global Consumer Conference TranscriptJun 14, 2022
- HALEON PLC at JPMorgan CEO Call Series TranscriptMay 20, 2022
- HALEON PLC at UBS Global Consumer & Retail Conference (Virtual) TranscriptMar 09, 2022
- GlaxoSmithKline PLC and HALEON PLC Consumer Healthcare Capital Markets Day TranscriptFeb 28, 2022
- HALEON PLC at UBS European Conference (Virtual) TranscriptNov 09, 2021
- HALEON PLC at Exane BNP Paribas European CEO Conference TranscriptJun 10, 2021
HALEON PLC at UBS European Conference (Virtual) Transcript
Hello, everyone, and welcome to this fireside chat. My name is Guillaume Delmas, I have the European food and HPC team here at UBS. So today, we are absolutely delighted to have with us Tobias Hestler, GSK Consumer Healthcare, Chief Financial Officer.
Tobias, thank you very much for taking the time today to answer our questions. Now, we've got half an hour. So for the purpose of today's fireside chat, I was thinking about starting with a focus on GSK Consumer Healthcare organic sales growth prospects before turning my attention to your margin opportunities.
And with that, let's begin.
Questions & Answers
So on organic sales growth, you anticipate medium-term category growth of 3% to 4% in oral care, 4% to 5% in VMS, 2% to 3% in OTC; which gives broadly a sales weighted average of around 3%. Now you've clearly stated that your ambition is to grow ahead of the market. So maybe can we start by you shedding some light of the main factors that should drive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)